-29.4%
TSCO vs MRNA
+945.0%
-974.4%
-47.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +4.2% | +13.1% | -8.9% | +4.1% |
| 7D | +15.7% | +20.6% | -4.9% | +15.5% |
| 30D | +16.4% | +27.1% | -10.7% | +16.0% |
| 3M | +11.2% | +353.4% | -342.2% | +7.6% |
| 6M | +14.9% | +446.3% | -431.3% | +9.8% |
| YTD | -25.4% | +776.2% | -801.6% | -31.4% |
| 1Y | -29.4% | +987.9% | -1,017.3% | -36.7% |
| All | -29.4% | +945.0% | -974.4% | -36.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling